May 19, 2013
(Samurai Trader,
8/8/12)
ESRX is one that gets more attention from IBD than from me, but it did tage what looks like a breakout from a cup and handle pattern, but with a couple of key flaws: relatively low volume and a weak price relative line....(read more)
(ValueWalk.com,
9/6/12)
Walgreen Company (NYSE:WAG) sales performance in August was, at best, weak, after the company posted a 4.5 percent sales decline to $5.85 billion from its $6.12 billion sales...(read more)
(Stock Blog Hub,
8/10/12)
Express Scripts Holding Company’s (ESRX) second-quarter 2012 adjusted earnings of 88 cents per share beat the Zacks Consensus Estimate of 82 cents and increased...(read more)
Express Scripts (ESRX) Company Overview
There is no analysis for ESRX yet. But you can go to Wikinvest to help create one!